TABLE 3.

Association of baseline SBP with clinical and radiographic outcomes in univariable and multivariable analysis.

	SBP ≥ 140 mm Hg vs. SBP < 140 mm Hg
	Unadjusted	p-value	Adjustedd	p-value
mRS score at 90 day (shift analysis toward poor outcome)	1.636 (1.240–2.158)a	0.001	1.509 (1.130–2.015)	0.005
mRS score 0–1 at 90 day	0.598 (0.411–0.870)b	0.007	0.619 (0.417–0.917)	0.017
mRS score 0–2 at 90 day	0.555 (0.395–0.780)b	0.001	0.563 (0.394–0.805)	0.002
mRS score 0–3 at 90 day	0.587 (0.424–0.812)b	0.001	0.598 (0.425–0.842)	0.003
Mortality at 90 day	1.553 (1.149–2.098)b	0.004	1.447 (1.055–1.985)	0.022
NIHSS score change from baseline at 24 h	1.936 (0.466–3.405)c	0.01	1.530 (0.012–3.048)	0.048
NIHSS score change from baseline at 5–7 days	2.802 (1.003–4.600)c	0.002	2.160 (0.303–4.016)	0.023
Successful reperfusion	0.525 (0.377–0.731)b	<0.001	0.550 (0.389–0.778)	0.001

mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and successful reperfusion means Modified Treatment in Cerebral Infarction score 2B–3.

^aThe common odds ratio was estimated from an ordinal logistic regression model and indicates the odds of deterioration of 1 point on the mRS.

^bThe odds ratios were estimated from a binary logistic regression model.

^cThe β value were estimated from a multivariable linear regression model.

^dAdjusted estimates of outcome were calculated using multiple regression, and considering the following variables: serum glucose, hypertension, atrial fibrillation, hyperlipidemia, and stroke causative mechanism.